Leonard Shultz to Rituximab
This is a "connection" page, showing publications Leonard Shultz has written about Rituximab.
Connection Strength
0.136
-
Verma MK, Clemens J, Burzenski L, Sampson SB, Brehm MA, Greiner DL, Shultz LD. A novel hemolytic complement-sufficient NSG mouse model supports studies of complement-mediated antitumor activity in vivo. J Immunol Methods. 2017 07; 446:47-53.
Score: 0.136